|
US2005042630A1
|
|
Method for the detection of asthma related gene transcripts in blood
|
|
US2004265869A1
|
|
Method for the detection of type II diabetes related gene transcripts in blood
|
|
US2004248170A1
|
|
Method for the detection of hyperlipidemia related gene transcripts in blood
|
|
US2004241728A1
|
|
Method for the detection of lung disease related gene transcripts in blood
|
|
US2005079514A1
|
|
Method for the detection of Alzheimer's disease related gene transcripts in blood
|
|
US2007105121A1
|
|
Method for the detection of schizophrenia related gene transcripts in blood
|
|
US2004241726A1
|
|
Method for the detection of allergies related gene transcripts in blood
|
|
US2005003394A1
|
|
Method for the detection of rheumatoid arthritis related gene transcripts in blood
|
|
US2004248169A1
|
|
Method for the detection of obesity related gene transcripts in blood
|
|
US2004241727A1
|
|
Method for the detection of schizophrenia related gene transcripts in blood
|
|
US2004265868A1
|
|
Method for the detection of depression related gene transcripts in blood
|
|
US2006134637A1
|
|
Method for the detection of cancer related gene transcripts in blood
|
|
US2005123938A1
|
|
Method for the detection of osteoarthritis related gene transcripts in blood
|
|
US2006134635A1
|
|
Method for the detection of coronary artery disease related gene transcripts in blood
|
|
AU2003272465A1
|
|
Identification of sequences particularly useful for the diagnosis and identification of therapeutic targets for osteoarthritis
|
|
US2004127445A1
|
|
Beta-2 microglobulin (B2M) and B2M related gene products for the regulation of osteoarthritis pathogenesis and chondrocyte proliferation
|
|
US2004037841A1
|
|
Compositions and methods relating to osteoarthritis
|
